Allogene Therapeutics Showcases Momentum with Clinical and Platform Advancements in Allogeneic CAR T at AACR 2026

Go back to Allogene Therapeutics Showcases Momentum with Clinical and Platform Advancements in Allogeneic CAR T at AACR 2026
(NASDAQ: ALLO) Delayed: 1.99 -0.01 (0.5%)
Previous Close $2.00    52 Week High
Open $1.99    52 Week Low
Day High $1.99    P/E N/A 
Day Low $1.99    EPS
Volume 44,696